Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
US-2025019364-A1 · Jan 16, 2025 · US
Hexamer Laura is listed as an inventor on 16 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Hexamer Laura |
| Total patents | 16 |
| First publication | Feb 10, 2015 |
| Latest publication | Jan 16, 2025 |
Publications ranked by popularity score, then publication date.
US-2025019364-A1 · Jan 16, 2025 · US
US-11897864-B2 · Feb 13, 2024 · US
US-2024043404-A1 · Feb 8, 2024 · US
US-2023143532-A1 · May 11, 2023 · US
US-2022315555-A1 · Oct 6, 2022 · US
US-2021221789-A1 · Jul 22, 2021 · US
US-2020231566-A1 · Jul 23, 2020 · US
US-2019119247-A1 · Apr 25, 2019 · US
US-2018251426-A1 · Sep 6, 2018 · US
US-2017158666-A1 · Jun 8, 2017 · US
Latest publications not already listed above.
US-9303025-B2 · Apr 5, 2016 · US
US-2015329541-A1 · Nov 19, 2015 · US
US-9174982-B2 · Nov 3, 2015 · US
US-9073855-B2 · Jul 7, 2015 · US
US-2015183775-A1 · Jul 2, 2015 · US
US-8952157-B2 · Feb 10, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Abbvie Inc | 16 |
| Genentech Inc | 11 |
| Walter & Eliza Hall Inst Medical Res | 8 |
| Inst Medical W & E Hall | 3 |
| Walter And Eliza Hall Institue Of Medical Res | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D401/12 | 16 |
| C07D403/12 | 15 |
| C07D471/04 | 15 |
| Y02A50/30 | 15 |
| C07D401/14 | 15 |